TransCode Therapeutics Announces Effective Date for 1-for-33 Reverse Stock Split
As previously announced, the 1-for-33 reverse stock split will automatically convert thirty-three current shares of TransCode’s common stock into one new share of common stock. No fractional shares ...
TransCode Therapeutics Announces Reverse Stock Split
TransCode Therapeutics ( (RNAZ) ) has provided an update.
Why Transcode Therapeutics (RNAZ) Stock Is Moving
Transcode Therapeutics shares are trading lower by 11% to 34 cents Monday afternoon. The company announced its Board's ...
Transcode Therapeutics issues 21.2M shares at 37.7c in private placement
TransCode Therapeutics (RNAZ) has entered into a securities purchase agreement with certain institutional investors. The aggregate gross cash proceeds are expected to be approximately $8M before ...
Nasdaq4d
TransCode Therapeutics Raises $8 Mln In Private Placement To Advance RNA Oncology Platform
(RTTNews) - TransCode Therapeutics, Inc. (RNAZ), a clinical-stage oncology company focused on RNA therapeutics, announced on Wednesday that it has entered into a securities purchase agreement to ...
Morningstar3d
TransCode Therapeutics Announces Effective Date for 1-for-33 Reverse Stock Split
BOSTON, Nov. 29, 2024 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (Nasdaq: RNAZ) (“TransCode” or the “Company”), the RNA Oncology Company™ committed to ...
Nasdaq4d
Transcode Therapeutics issues 21.2M shares at 37.7c in private placement
TransCode Therapeutics (RNAZ) has entered into a securities purchase agreement with certain institutional investors. The aggregate gross cash proceeds are expected to be approximately $8M before ...
Stockhouse2d
TransCode Therapeutics Announces Effective Date for 1-for-33 Reverse Stock Split
BOSTON, Nov. 29, 2024 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (Nasdaq: RNAZ) (“TransCode” or the “Company”), the RNA Oncology Company™ committed to ...